Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Catalyst Pharmaceuticals (CPRX) Receivables - Net (2019 - 2026)

Catalyst Pharmaceuticals filings provide 8 years of Receivables - Net readings, the most recent being $130.8 million for Q1 2026.

  • On a quarterly basis, Receivables - Net rose 83.59% to $130.8 million in Q1 2026 year-over-year; TTM through Mar 2026 was $130.8 million, a 83.59% increase, with the full-year FY2025 number at $126.5 million, up 93.17% from a year prior.
  • Receivables - Net hit $130.8 million in Q1 2026 for Catalyst Pharmaceuticals, up from $126.5 million in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $130.8 million in Q1 2026 to a low of $9.3 million in Q3 2022.
  • Median Receivables - Net over the past 5 years was $57.2 million (2024), compared with a mean of $56.5 million.
  • Biggest five-year swings in Receivables - Net: surged 414.61% in 2023 and later grew 15.2% in 2025.
  • Catalyst Pharmaceuticals' Receivables - Net stood at $10.4 million in 2022, then skyrocketed by 412.64% to $53.5 million in 2023, then rose by 22.35% to $65.5 million in 2024, then surged by 93.17% to $126.5 million in 2025, then grew by 3.44% to $130.8 million in 2026.
  • The last three reported values for Receivables - Net were $130.8 million (Q1 2026), $126.5 million (Q4 2025), and $106.4 million (Q3 2025) per Business Quant data.